News

We're not just shaping technology; we're shaping the future.

News

Launch of Point-of-Care Reagents for Rapid Infectious Disease Detection

A new line of point-of-care reagents is launched, enabling rapid detection of various infectious diseases. The portable and easy-to-use testing kits empower healthcare professionals to diagnose patients quickly, leading to timely treatment interventions and better disease management.

Collaborative Effort Leads to Affordable HIV Testing Reagents

A collaboration between research institutions and pharmaceutical companies results in the development of affordable HIV testing reagents. The initiative aims to improve access to HIV diagnostics in resource-limited settings, potentially saving millions of lives.

FDA Approval for Next-Generation Cancer Biomarker Detection Reagent

A cutting-edge reagent designed for the detection of specific cancer biomarkers receives FDA approval. The innovative technology offers oncologists a more precise and efficient tool for diagnosing and monitoring cancer patients.

Breakthrough in COVID-19 Testing Reagent Development

Researchers have announced a groundbreaking development in COVID-19 testing reagents, poised to revolutionize diagnostic protocols worldwide. This new formulation enhances accuracy and speed, addressing critical challenges faced by global healthcare systems in the pandemic.